Libero logo

MeRes100 BRS - the World's First Thin Strut Sirolimus-Eluting Bioresorbable Vascular Scaffold - Shows Consistent Long-term Positive Safety With Consistent Low MACE Rates and Zero Scaffold Stent Thrombosis for Patients With Coronary Artery Disease

di AdnKronosdomenica 14 luglio 2019